Shannon Myers Virtue1, Sharon L Manne2, Laura Mee3, Abraham Bartell4, Stephen Sands5, Tina Marie Gajda2, Kathleen Darabos2. 1. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. Electronic address: myerssb@cinj.rutger.edu. 2. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. 3. Emory University School of Medicine, Atlanta, GA, USA. 4. Memorial Sloan Kettering Cancer Center, New York, NY, USA. 5. Columbia University Medical Center, New York, NY, USA.
Abstract
OBJECTIVE: The aims of the study were to examine the prevalence of self-reported psychological distress, examine the prevalence of interview-rated psychiatric diagnoses, identify correlates of psychological distress and psychiatric diagnosis and examine racial/ethnic group differences on measures of psychological distress among primary caregivers of children preparing to undergo hematopoietic stem cell transplant (HSCT). METHODS: Caregivers (N = 215) completed the Beck Anxiety Inventory, Beck Depression Inventory (BDI), Impact of Events Scale, and a psychiatric interview assessing major depressive disorder, generalized anxiety disorder and panic disorder. Regression analyses examined correlates of distress and psychiatric diagnosis. Comparisons were made between racial/ethnic groups. RESULTS: Posttraumatic stress symptoms were reported by 54% of caregivers during the time preparing for the child's HSCT. Twenty-seven percent of caregivers met diagnostic criteria for at least one of the psychiatric diagnoses during this time. Few factors were associated with distress or psychiatric diagnosis, except the child scheduled for allogeneic transplant, being married and prior psychological/psychiatric care. Sociodemographic factors accounted for racial/ethnic group differences, except that Hispanic/Latino caregivers reported higher BDI scores than non-Hispanic white caregivers. CONCLUSION: Caregivers may be at greater risk of posttraumatic stress symptoms than anxiety or depression. Prior psychological/psychiatric treatment is a risk factor for greater psychological distress and psychiatric diagnosis during this time. Racial differences are mostly due to sociodemographic factors.
OBJECTIVE: The aims of the study were to examine the prevalence of self-reported psychological distress, examine the prevalence of interview-rated psychiatric diagnoses, identify correlates of psychological distress and psychiatric diagnosis and examine racial/ethnic group differences on measures of psychological distress among primary caregivers of children preparing to undergo hematopoietic stem cell transplant (HSCT). METHODS: Caregivers (N = 215) completed the Beck Anxiety Inventory, Beck Depression Inventory (BDI), Impact of Events Scale, and a psychiatric interview assessing major depressive disorder, generalized anxiety disorder and panic disorder. Regression analyses examined correlates of distress and psychiatric diagnosis. Comparisons were made between racial/ethnic groups. RESULTS:Posttraumatic stress symptoms were reported by 54% of caregivers during the time preparing for the child's HSCT. Twenty-seven percent of caregivers met diagnostic criteria for at least one of the psychiatric diagnoses during this time. Few factors were associated with distress or psychiatric diagnosis, except the child scheduled for allogeneic transplant, being married and prior psychological/psychiatric care. Sociodemographic factors accounted for racial/ethnic group differences, except that Hispanic/Latino caregivers reported higher BDI scores than non-Hispanic white caregivers. CONCLUSION: Caregivers may be at greater risk of posttraumatic stress symptoms than anxiety or depression. Prior psychological/psychiatric treatment is a risk factor for greater psychological distress and psychiatric diagnosis during this time. Racial differences are mostly due to sociodemographic factors.
Authors: Anne E Kazak; C Alexandra Boeving; Melissa A Alderfer; Wei-Ting Hwang; Anne Reilly Journal: J Clin Oncol Date: 2005-09-12 Impact factor: 44.544
Authors: Joshua Breslau; Sergio Aguilar-Gaxiola; Kenneth S Kendler; Maxwell Su; David Williams; Ronald C Kessler Journal: Psychol Med Date: 2005-10-05 Impact factor: 7.723
Authors: H C Maltezou; D A Kafetzis; D Abisaid; E C Mantzouranis; K W Chan; K V Rolston Journal: Pediatr Infect Dis J Date: 2000-04 Impact factor: 2.129
Authors: W L Hobbie; M Stuber; K Meeske; K Wissler; M T Rourke; K Ruccione; A Hinkle; A E Kazak Journal: J Clin Oncol Date: 2000-12-15 Impact factor: 44.544
Authors: C M J Vrijmoet-Wiersma; R M Egeler; H M Koopman; A Lindahl Norberg; M A Grootenhuis Journal: Support Care Cancer Date: 2009-07-02 Impact factor: 3.603
Authors: Eden Brauer; Huibrie C Pieters; Patricia A Ganz; Wendy Landier; Carol Pavlish; MarySue V Heilemann Journal: Oncol Nurs Forum Date: 2018-03-01 Impact factor: 2.172
Authors: Crystal Natvig; Susan K Mikulich-Gilbertson; Mark L Laudenslager; Cathy J Bradley Journal: J Cancer Surviv Date: 2021-08-21 Impact factor: 4.062
Authors: Stephen A Sands; Laura Mee; Abraham Bartell; Sharon Manne; Katie A Devine; Mirko Savone; Deborah A Kashy Journal: J Pediatr Psychol Date: 2017-04-01
Authors: Christina K Ullrich; Angie Mae Rodday; Kristin Bingen; Mary Jo Kupst; Sunita K Patel; Karen L Syrjala; Lynnette L Harris; Christopher J Recklitis; Lisa Schwartz; Stella Davies; Eva C Guinan; Grace Chang; Joanne Wolfe; Susan K Parsons Journal: Biol Blood Marrow Transplant Date: 2015-09-05 Impact factor: 5.742
Authors: Kristen A Russ; Steven J Holochwost; Susan M Perkins; Kristin Stegenga; Seethal A Jacob; David Delgado; Amanda K Henley; Joan E Haase; Sheri L Robb Journal: J Altern Complement Med Date: 2020-02-19 Impact factor: 2.579
Authors: Steven J Holochwost; Sheri L Robb; Amanda K Henley; Kristin Stegenga; Susan M Perkins; Kristen A Russ; Seethal A Jacob; David Delgado; Joan E Haase; Caitlin M Krater Journal: Front Psychol Date: 2020-11-02
Authors: Claudia Carmassi; Valerio Dell'Oste; Claudia Foghi; Carlo Antonio Bertelloni; Eugenia Conti; Sara Calderoni; Roberta Battini; Liliana Dell'Osso Journal: Int J Environ Res Public Health Date: 2020-12-29 Impact factor: 3.390